MetaCap

Baird Medical Investment (BDMD) vs NeuroOne Medical Technologies (NMTC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

NeuroOne Medical Technologies (NMTC) has outperformed Baird Medical Investment (BDMD) over the past year, losing 82.9% versus a loss of 93.6%. NeuroOne Medical Technologies is the larger company by market cap ($5.9 million vs $5.1 million), about 1.2 times the size. NeuroOne Medical Technologies converts more of its revenue into profit, with a net margin of -39.6% versus -121.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BDMD-93.64%NMTC-82.91%
+156%+25%-106%
Nov 21, 20251 yearNov 20, 2026
BDMD-99.08%NMTC-94.82%
+48%-29%-106%
Dec 13, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BDMD versus NMTC key metrics
MetricBDMDNMTC
Share price$0.0897$0.6521
Market cap$5.07M$5.94M
1-day change-12.91%-3.38%
YTD return-93.40%-85.66%
1-year return-93.64%-82.91%
5-year return—-95.19%
Forward P/E0.64—
EPS (TTM)$-0.55$-0.99
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$22.54M$9.10M
Revenue growth (YoY)-39.15%+163.47%
Net income (latest FY)$-27.28M$-3.61M
Gross margin83.79%56.51%
Operating margin-113.73%-46.46%
Net margin-121.04%-39.63%
52-week high$3.70$6.12
52-week low$0.073$0.61
Distance from 52-week high-97.58%-89.34%
Analyst consensusnonestrong_buy
Avg. price target upside+4359.31%+1014.86%
Average volume16.31M337.67K
Shares outstanding56.52M9.11M
Employees14618
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • NMTC has outperformed BDMD by 10.7 percentage points over the past year.
  • NeuroOne Medical Technologies is more profitable, keeping -39.6 cents of every revenue dollar as net income versus -121.0 cents for Baird Medical Investment.
  • NeuroOne Medical Technologies grew revenue faster in its latest fiscal year (+163.47% vs -39.15%).

About Baird Medical Investment

BDMD stock →

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation.

Health Care · Medical/Dental Instruments · 146 employees

About NeuroOne Medical Technologies

NMTC stock →

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.

Health Care · Medical/Dental Instruments · 18 employees

BDMD vs NMTC FAQ

Which is bigger, Baird Medical Investment or NeuroOne Medical Technologies?

NeuroOne Medical Technologies (NMTC) is larger, with a market capitalization of $5.94M compared with $5.07M for Baird Medical Investment (BDMD).

Which stock has performed better over the past year, BDMD or NMTC?

NMTC returned -82.91% over the past 12 months, compared with -93.64% for BDMD (price return, excluding dividends). Past performance does not predict future results.

Are Baird Medical Investment and NeuroOne Medical Technologies in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons